Five-Star Business Finance Earnings Call: Key Takeaways
Five-Star Business Finance reported FY26 PAT of ₹10,988 Mn (+2% YoY) and AUM growth of 11% to ₹132,246 Mn. Strategy focuses on secured lending to small businesses via proprietary underwriting.
ALFA Filings
Every announcement, straight from the exchange
Every corporate announcement our alert engine sent, newest first: orders, results, earnings calls, fund raises, board meetings and more.
Announcement type
Time
149,550 announcements with these filters
Five-Star Business Finance reported FY26 PAT of ₹10,988 Mn (+2% YoY) and AUM growth of 11% to ₹132,246 Mn. Strategy focuses on secured lending to small businesses via proprietary underwriting.
Somany Ceramics Limited has scheduled a Board Meeting for May 4, 2026, to consider audited financial results and a proposal for an interim dividend. The trading window for designated persons remains closed from April 1, 2026, until 48 hours after the results declaration.
Piramal Pharma Limited announced its FY26 results, reporting revenue of ₹8,869 Crore. Performance was impacted by inventory destocking and slower inflows, although the company maintained a strong quality track record with zero OAI. Management remains optimistic for FY27 growth driven by the CDMO and CHG businesses.
Manaksia Aluminium Company Ltd clarified that recent stock price movements are purely market-driven. The company confirmed it is in full compliance with SEBI listing regulations and has disclosed all material, price-sensitive information to the exchanges.
Emmvee Photovoltaic Power Ltd reported FY2026 revenue of ₹5,049.9 Crore, up 116% year-on-year, while PAT tripled to ₹1,081.6 Crore. The company expanded module capacity to 10.3 GW and plans further expansion to 16.3 GW by FY2028. Strong performance was driven by solar cell operations and manufacturing scale benefits.
OneSource Specialty Pharma Limited received an EU GMP Certificate for its Sterile Product Division in Bangalore from German authorities. The certification follows an October 2025 inspection and covers aseptic liquids, secondary packing, and quality control. This approval complements existing US-FDA, Health Canada, ANVISA, and TGA clearances, strengthening the facility's global sterile manufacturing capabilities.
Life Insurance Corporation of India (LIC) announced the cessation of Shri Vinod Kumar Verma and Dr. Ranjan Sharma as Independent Directors following the completion of their terms on April 28, 2026. Consequently, they also stepped down from their respective board committee positions.
Five-Star Business Finance reported its FY2026 results, achieving an 11% AUM growth to ₹13,225 Crore and a 2% PAT increase to ₹1,099 Crore. The company expanded its network to 844 branches, opening 9 new units during Q4. Despite asset quality headwinds, management noted improving collection efficiencies and expects 20% AUM growth for FY2027.
Rossari Biotech Limited's board has recommended a final dividend of 25% (Rs. 0.50 per equity share) for the financial year 2025-26. The record date and general meeting date for shareholder approval will be announced later.
Piramal Pharma Ltd reported revenue from operations of ₹2,752 Cr (-0.1% YoY) and a net loss of ₹8.8 Cr for Q4 FY26.
Piramal Pharma Limited reported its FY2026 audited financial results, showing standalone annual revenue of ₹4,782.01 Crore and PAT of ₹700.01 Crore. The Board also approved the re-appointment of Ms. Nandini Piramal as Chairperson and Mr. Peter DeYoung as Executive Director, alongside shifting the company's registered office and appointing a new Company Secretary.
Mitshi India Ltd reported revenue from operations of ₹1.3 Cr (+30.0% YoY) and net profit of ₹0 Cr for Q4 FY26.
Mitshi India Ltd approved its audited standalone financial results for the year ended March 31, 2026. The company reported annual income of ₹2.77 Crore and a net profit of ₹0.69 Lakhs. The auditor's report contains a qualified opinion regarding substantial cash transactions and pending confirmations for certain balances.
Rossari Biotech Limited announced that Ms. Aparna Sharma completed her tenure as Non-Executive Independent Director effective April 28, 2026. This is a routine board transition following the completion of an appointed term.
Equity shareholders of Torrent Pharmaceuticals Limited approved the Scheme of Amalgamation with J. B. Chemicals & Pharmaceuticals Limited. The resolution was passed with the requisite majority through remote e-voting and e-voting at the NCLT-convened meeting held on April 28, 2026.
Kartik Investments Trust Ltd has scheduled a Board of Directors meeting on May 5, 2026, to approve audited financial results for the year ended March 31, 2026. Consequently, the trading window for designated persons is closed from April 1 to May 7, 2026.
AWL Q4'26 saw 18% revenue and 54% PAT growth (consolidated) driven by edible oil volume expansion (17% YoY). Standalone PAT surged 71%.
Bajaj Finance Limited granted 1,48,07,966 stock options to employees under its ESOP Scheme 2009. Each option is convertible into one equity share of Re. 1 face value. Options vest between one and five years from the grant date, with an exercise price linked to the latest market closing price.
Greenply Industries announced the resignation of Mr. Manoj Tulsian as Joint Managing Director and CEO, effective May 1, 2026. Simultaneously, the board approved the re-appointment of Ms. Vinita Bajoria as an Independent Director for a five-year term starting September 15, 2026, subject to shareholder approval.
Refex Industries Limited announced that the Hon’ble Madras High Court has quashed an Income Tax demand of ₹35.67 Crore for AY 2016–17. The court set aside the assessment order on the grounds that it was passed without providing a reasonable opportunity of being heard. Consequently, the tax liability stands nullified.
Fedbank achieved record ₹100cr quarterly PAT and ₹20,000cr AUM, driven by massive 135% YoY gold loan disbursement growth. Management is pivoting to a fully secured lending model, successfully exiting unsecured business loans.
Indus Towers Limited has scheduled a Board Meeting for April 30, 2026, to consider and recommend a dividend for shareholders. The company's trading window has been closed from March 31, 2026, until May 2, 2026, in accordance with SEBI PIT Regulations.
Hero FinCorp Limited reported revenue from operations of ₹2,330 Cr (-6.9% YoY) and net profit of ₹5.7 Cr (-86.0% YoY) for Q4 FY26.
Prozone Realty approved the sale of three material subsidiaries to Inorbit Malls for approximately ₹1,242.50 Crore. The board also cleared the internal transfer of Coimbatore and Chhatrapati Sambhaji Nagar land assets into separate SPVs and a 17.507% stake acquisition in GPDPL for ₹24 Crore. These strategic moves aim to facilitate disinvestment and expand high-income yielding assets.
Emmvee Photovoltaic Power Ltd reported revenue from operations of ₹1,739 Cr (+62.2% YoY) and net profit of ₹392.4 Cr (+89.5% YoY) for Q4 FY26.
Emmvee Photovoltaic Power Ltd reported audited financial results for FY 2025-26. The company also recommended a final dividend of ₹1 per equity share (50% of face value). Consolidated total income for the year stood at ₹5,103.39 Crore with a net profit of ₹1,081.55 Crore, reflecting significant year-on-year growth.
Five-Star Business Finance Limited reported nil deviation in the utilisation of proceeds from its preferential issue of share warrants as of March 31, 2026. The company has utilised ₹7.89 Crore of upfront consideration, while ₹17.90 Crore received on warrant conversion remains unutilised.
Go Digit reported strong FY26 performance with a 17.7% ROE and significant GWP growth, transitioning to new Indian Accounting Standards (Ind AS) which notably increased their net worth by ₹3,000 crore.
Zen Technologies Limited announced the successful passage of three resolutions via postal ballot with requisite majority. Shareholders approved material related party transactions with Unistring Tech Solutions and the re-appointment of Mr. Ashok Atluri as Chairman & MD and Mr. Kishore Dutt Atluri as President & Joint MD. The remote e-voting concluded on April 24, 2026.
SBI Life reported strong FY26 performance with 20% growth in New Business Premium and 12% VNB growth. Focus remains on product diversification towards Non-PAR and protection segments while leveraging a multi-channel distribution strategy.